Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta …

YR Huo, GD Eslick - JAMA oncology, 2015 - jamanetwork.com
… We evaluated the efficacy and safety of transcatheter arterial chemoembolization (TACE)
plus radiotherapy (RT) compared with TACE alone for unresectable hepatocellular carcinoma

[HTML][HTML] Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma

WJ Guo, EX Yu, LM Liu, J Li, Z Chen… - World Journal of …, 2003 - ncbi.nlm.nih.gov
… plus irradiation group and TACE alone group. A multivariate … was higher than that in TACE
alone group (47.4% vs 28.1%, P … of TACE alone for the treatment of large unrectable HCC. …

Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies

L Marelli, R Stigliano, C Triantos, M Senzolo… - Cancer treatment …, 2006 - Elsevier
… and December 2005; among these, 11 dealt with chemoembolization alone compared to
other treatments and the remaining 73 with chemoembolization combined with other therapies. …

Chemoembolization for hepatocellular carcinoma

J Bruix, M Sala, JM Llovet - Gastroenterology, 2004 - Elsevier
… Third is whether there is an additive or synergistic effect between arterial embolization and
chemotherapy, and thus whether chemoembolization is better than embolization alone. And …

Medium-sized (3.1–5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone

JH Kim, HJ Won, YM Shin, SH Kim, HK Yoon… - Annals of surgical …, 2011 - Springer
… RFA is safe and provided better local tumor control than RFA alone in treating patients with
medium-sized HCC. Our multivariate analysis showed that RFA-alone treatment (P = 0.016) …

[HTML][HTML] Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients

S Gao, PJ Zhang, JH Guo, H Chen, HF Xu… - World Journal of …, 2015 - ncbi.nlm.nih.gov
… observed between the chemoembolization alone and chemoembolization + HAIC …
chemoembolization + HAIC group showed better mPFS when compared to chemoembolization

… trial comparing transarterial chemoembolization plus sorafenib to transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma

M Kudo, K Ueshima, M Ikeda, T Torimura, N Tanabe… - Liver cancer, 2022 - karger.com
… unresectable hepatocellular carcinoma: chemoembolizationchemoembolization in patients
with hepatocellular carcinoma… with TACE alone in patients with hepatocellular carcinoma: …

… combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score …

H Hu, Z Duan, X Long, Y Hertzanu, H Shi, S Liu… - PloS one, 2014 - journals.plos.org
… the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus
TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC). …

Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses

GH Choi, JH Shim, MJ Kim, MH Ryu, BY Ryoo… - Radiology, 2013 - pubs.rsna.org
Purpose To compare the time to progression (TTP) and overall survival (OS) in patients with
advanced-stage hepatocellular carcinoma (HCC) who are undergoing sorafenib treatment …

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone …

T Shibata, H Isoda, Y Hirokawa, S Arizono, K Shimada… - Radiology, 2009 - pubs.rsna.org
Hepatocellular carcinoma (HCC) has gained major clinical interest because of its … Liver
cancer is the fifth most common cancer in the world and the third cause of cancer-related death (2…